Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • ELISA Kits
  • MACS Cell Isolation
  • Antibodies and Reagents
  • Apoptosis and Cell Health Detection
  • Metabolism Assays
  • Immunoassays
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑
Recombinant ABL1 Monoclonal Antibody - 1
  • Recombinant ABL1 Monoclonal Antibody - 1
  • Recombinant ABL1 Monoclonal Antibody - 2
All Size Price Qty
100μL $ 320.00
- +
50μL $ 211.00
- +
Add to cart

For research use only.

Verified Samples Verified Samples in WB: Hela
Dilution WB 1:2000-1:10000
Isotype IgG,κ
Host Rabbit
Reactivity Human
Applications WB
Clonality Monoclonal;Recombinant
Immunogen Recombinant Human ABL1 protein
Abbre ABL1
Synonyms JTK,  Tyrosine-protein kinase ABL,  Abelson tyrosine-protein kinase,  Abelson murine leukemia viral oncogene homolog,  ABL,  JTK7,  p150,  c-ABL,  v-abl,  CHDSKM,  c-ABL1,  ABL1,  bcr/abl,  JTK7),  Tyrosine-protein kinase ABL1,  ABL1 (ABL),  Abelson murine leukemia viral oncogene homolog 1,  Abelson tyrosine-protein kinase 1,  Abelson tyrosine protein kinase 1,  Abl 1,  ABL proto oncogene 1 non receptor tyrosine kinase,  bcr/c abl oncogene protein,  c ABL,  c abl oncogene 1 non receptor tyrosine kinase,  c abl oncogene 1 receptor tyrosine kinase,  c ABL1,  Proto oncogene tyrosine protein kinase ABL1,  Proto-oncogene c-Abl,  v abl,  v abl Abelson murine leukemia viral oncogene homolog 1
Swissprot
Calculated MW 123 kDa
Observed MW 123 kDa

Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include:

1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein.

2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes.

3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1.

4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids).

5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers.

If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane.

Cellular Localization Cytoplasm > cytoskeleton. Nucleus. Sequestered into the cytoplasm through interaction with 14-3-3 proteins and Nucleus membrane. The myristoylated c-ABL protein is reported to be nuclear.
Concentration 0.2 mg/mL
Buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method Protein A
Research Areas Signal Transduction,  Epigenetics and Nuclear Signaling,  Cancer
Clone No. 5H6
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping Ice bag
background This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons.
Other Clones

{{antibodyDetailsPage.numTotal}} Results

Other Formats

{{formatDetailsPage.numTotal}} Results

Unconjugated

  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.organization}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

Product Information